论文部分内容阅读
东菱精纯克栓酶(DF—521)是一种单成分溶血栓促微循环的新型血栓治疗剂,我科ICU病房自1994年10月～1995年7月用该药治疗缺血性脑卒中(脑梗塞、脑栓塞)共46例,现分析报告如下。 1 资料和方法 1.1 所有患者均为来院ICU住院病人。46例中5例诊断为脑栓塞(有风湿性心脏病、心房纤维性颤动病史),男2例,女3例,年龄37～62岁;脑梗塞41例,男22例,女19例,年龄48～75岁。发病距用药时间<6h3例,6～24 h27例,1～3 d8例,3～7 d5例,1～2周2例,3周1例。所有患者均有神经定位及肢体瘫痪症状,经头颅CT证实。脑梗塞体积(ml)按Pullicino公式计算,即脑梗塞体积(ml)=长×宽×CT扫描阳性层次
DF-521 is a new thrombolytic agent for single component thrombolysis microcirculation. ICU ward of our department treated the ischemic brain from October 1994 to July 1995 Stroke (cerebral infarction, cerebral embolism) a total of 46 cases, the analysis report is as follows. 1 Materials and Methods 1.1 All patients were hospitalized to hospital ICU patients. Among the 46 cases, 5 cases were diagnosed as cerebral embolism (history of rheumatic heart disease and atrial fibrillation). There were 2 males and 3 females, aged from 37 to 62 years. There were 41 cases of cerebral infarction, 22 males and 19 females, Age 48 to 75 years old. The incidence of medication from the time of 6h3 cases, 6 to 24 h in 27 cases, 1 to 3 d8 cases, 3 to 7 d5 cases, 1 to 2 weeks in 2 cases, 3 weeks in 1 case. All patients had neurological location and paralysis of limbs confirmed by skull CT. The volume of cerebral infarction (ml) was calculated according to the Pullicino formula, that is, the infarct volume (ml) = length × width × CT scan positive level